LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 52 filers reported holding LEAP THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,287,009 | -24.4% | 6,726,496 | 0.0% | 0.07% | -20.0% |
| Q4 2022 | $3,026,923 | -54.0% | 6,726,496 | -10.0% | 0.08% | -55.5% |
| Q3 2022 | $6,575,000 | -28.1% | 7,472,148 | -6.0% | 0.19% | -33.2% |
| Q2 2022 | $9,144,000 | -34.3% | 7,951,448 | 0.0% | 0.29% | +2.5% |
| Q1 2022 | $13,915,000 | -74.7% | 7,951,448 | -53.1% | 0.28% | -34.2% |
| Q4 2021 | $54,926,000 | +61.6% | 16,952,992 | +100.0% | 0.42% | -14.2% |
| Q3 2021 | $33,990,000 | +22.3% | 8,476,496 | -50.0% | 0.49% | +172.9% |
| Q2 2021 | $27,802,000 | +72.6% | 16,952,992 | +100.0% | 0.18% | -11.3% |
| Q1 2021 | $16,105,000 | -15.6% | 8,476,496 | 0.0% | 0.20% | -0.5% |
| Q4 2020 | $19,072,000 | +13.6% | 8,476,496 | 0.0% | 0.20% | -16.3% |
| Q3 2020 | $16,783,000 | -3.9% | 8,476,496 | 0.0% | 0.24% | -13.4% |
| Q2 2020 | $17,466,000 | +64.4% | 8,476,496 | +26.0% | 0.28% | +2.2% |
| Q1 2020 | $10,627,000 | – | 6,726,496 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 904,600 | $2,035,000 | 1.08% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 275,000 | $619,000 | 0.36% |
| Perceptive Advisors | 8,476,496 | $19,072,000 | 0.20% |
| SPHERA FUNDS MANAGEMENT LTD. | 800,000 | $1,800,000 | 0.16% |
| Golden Green, Inc. | 69,580 | $157,000 | 0.15% |
| Artal Group S.A. | 3,000,000 | $6,750,000 | 0.14% |
| HHLR ADVISORS, LTD. | 3,716,240 | $8,362,000 | 0.07% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,065,259 | $2,397,000 | 0.06% |
| Windsor Creek Advisors, LLC | 89,972 | $202,000 | 0.05% |
| PERSONAL CFO SOLUTIONS, LLC | 73,165 | $165,000 | 0.04% |